リポソームドラッグデリバリーデバイスの世界市場レポート 2024年

リポソームドラッグデリバリーデバイスの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.4%の年間複合成長率（CAGR）で77億1,000万米ドルに成長すると予想されます。予測される成長は、標的療法、臨床試験、個別化医療の焦点、併用療法、規制変更によるものです。動向には、生体適合性材料、送達の革新、腫瘍学への応用、併用療法、とリポソームドラッグデリバリーにおけるカスタマイズ型製剤が含まれます。

世界のがん症例の増加は、予測期間中のリポソームドラッグデリバリーデバイス市場の成長の促進要因となる準備ができています。リポソームドラッグデリバリーシステムは、放射線療法、化学療法、外科的切除を含む標的がん治療において極めて重要な役割を果たします。注目すべきことに、米国がん協会は、2021年に米国で新たに190万人のがん患者が発生し、60万人ががんに関連して死亡したと報告しました。肺がん、前立腺がん、腸がん、女性の乳がんが合わせて全世界の新規症例の43%を占め、がんの急増により世界の金利の上昇により、今後数年間でリポソームドラッグデリバリーデバイスの需要が大幅に高まることが予想されます。

予想される医療支出の増加により、リポソームドラッグデリバリーデバイス市場の拡大が促進されると予想されます。医療支出の増加に寄与する要因には、慢性疾患の有病率の上昇、医療技術の進歩、薬価の高騰、消費者の期待、保険費用の増加などが含まれます。医療支出には、調査、開発、製造、流通、リポソームドラッグデリバリーシステムなどの医療技術の利用など、さまざまな側面が含まれます。 2022年 7月、Peter G Foundationは、米国の公的と民間の医療支出が2022年の4兆4,000億米ドルから2031年には7兆2,000億米ドルに増加すると予測しました。経済成長を上回るこの支出の増加は、医療の成長を促進すると予想されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のリポソームドラッグデリバリーデバイス市場の促進要因のドラッグデリバリー要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のリポソームドラッグデリバリーデバイスの市場規模実績と成長、2018～2023年
• 世界のリポソームドラッグデリバリーデバイス市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のリポソームドラッグデリバリーデバイス市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• リポソームドキソルビシン
• リポソームパクリタキセル
• リポソームアムホテリシンB
• その他
• 世界のリポソームドラッグデリバリーデバイス市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 真菌性疾患
• がん治療
• 疼痛管理
• ウイルスワクチン
• 光線力学療法
• 世界のリポソームドラッグデリバリーデバイス市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 診断センター
• 外来手術センター/クリニック
• その他

第7章 地域と国の分析

• 世界のリポソームドラッグデリバリーデバイス市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のリポソームドラッグデリバリーデバイス市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• リポソームドラッグデリバリーデバイス市場の競合情勢
• リポソームドラッグデリバリーデバイス市場企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson Services Inc.
  • Merck &Co. Inc.
  • Novartis AG
  • Medtronic plc

第31章 その他の大手と革新的な企業

• Gilead Sciences Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Sun Pharmaceutical Industries Ltd.
• CSPC Pharmaceutical Group Limited
• Ipsen SA
• Novavax Inc.
• Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd.
• Nanomerics Ltd.
• Luye Pharma Group Ltd.
• Leadiant Biosciences Inc.
• Pacira Biosciences Inc.
• Tolmar Pharmaceuticals Inc.
• Nippon Kayaku Co. Ltd.
• Celsion Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Liposomal drug delivery devices are microscopic colloidal spheres utilized to transport drug molecules to specific action sites.

Primary types encompass liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. Liposomal doxorubicin, a chemotherapy drug under the anthracycline category, encapsulated within a liposome, inhibits cancer cell growth by blocking the enzyme topoisomerase. These devices find applications in treating fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy, utilized in hospitals, diagnostic centers, ambulatory surgery centers/clinics, and similar medical settings.

The liposomal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides liposomal drug delivery devices market statistics, including liposomal drug delivery devices industry global market size, regional shares, competitors with a liposomal drug delivery devices market share, detailed liposomal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the liposomal drug delivery devices industry. This liposomal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liposomal drug delivery devices market size has grown rapidly in recent years. It will grow from $4.52 billion in 2023 to $5.02 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historical period can be attributed to several factors, including advancements in drug delivery techniques, biomedical research progress, clinical validation of these methods, diverse therapeutic applications, and improvements in biocompatibility, collectively contributing to the expansion of liposomal drug delivery devices.

The liposomal drug delivery devices market size is expected to see rapid growth in the next few years. It will grow to $7.71 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. Anticipated growth is from targeted therapies, clinical trials, personalized medicine focus, combination therapies, and regulatory changes. Trends include biocompatible materials, delivery innovations, oncology applications, combination therapies, and customized formulations in liposomal drug delivery.

The escalating global incidence of cancer cases is poised to be a driving factor in the growth of the liposomal drug delivery devices market during the forecast period. Liposomal drug delivery systems play a pivotal role in targeted cancer therapy, encompassing radiation therapy, chemotherapy, and surgical resection. Notably, the American Cancer Society reported 1.9 million new cancer cases and 0.6 million cancer-related deaths in the USA in 2021. With lung, prostate, bowel, and female breast cancer collectively constituting 43% of all new cases globally, the surge in cancer rates worldwide is expected to significantly enhance the demand for liposomal drug delivery devices in the coming years.

The anticipated upswing in healthcare expenditure is set to propel the expansion of the liposomal drug delivery devices market. Factors contributing to the rise in healthcare spending include the heightened prevalence of chronic diseases, advancements in medical technology, escalating drug prices, consumer expectations, and increasing insurance costs. Healthcare expenditure encompasses various facets, including research, development, manufacturing, distribution, and utilization of medical technologies such as liposomal drug delivery systems. In July 2022, the Peter G Foundation projected that both public and private healthcare spending in the United States would increase from $4.4 trillion in 2022 to $7.2 trillion in 2031. This rise in expenditure, outpacing economic growth, is anticipated to foster the growth of the liposomal drug delivery devices market.

The elevated cost associated with liposomal drug delivery devices is expected to impede the market's growth during the forecast period. The high cost of these devices renders liposomal treatments prohibitively expensive for patients, posing a constraint on market expansion. Notably, lipid/liposomal drug delivery systems are reported to be costly to produce, attributed to the high production cost associated with raw materials such as lipid excipients and the necessity for expensive equipment in the manufacturing process. Moreover, according to the ScienceDirect Journal, liposomal drug delivery stands out as the most expensive treatment for topical disorders such as psoriasis, atopic dermatitis, and skin cancer.

Prominent companies in the liposomal drug delivery devices market are actively engaging in strategic initiatives such as collaborations and new product development, emerging as a prevailing trend in the industry. These companies are forming partnerships to jointly develop liposomal drug delivery systems, aiming to broaden their product portfolios and enhance global operations. A notable example is the collaboration between MindMed, an Israeli creative drug development company, and Nextage, where a Memorandum of Understanding was executed in 2021. This collaboration focused on optimizing the supply of specific psychedelic drug candidates using Nextage's proprietary Brain Targeting Liposome System (BTLS) supply technology, under license.

Major players in the liposomal drug delivery market are introducing innovative products, including liposomal nanostructures, as a strategic move to gain a competitive advantage. Researchers are dedicated to developing liposomal nanostructures designed to enhance patient compliance by allowing less frequent doses while maintaining efficacy. An illustrative example comes from February 2022, where commercial nano-liposomal products, such as Onivyde, Vyxeos, and Marqibo, have been introduced and approved for use. These medications, employed in the treatment of cancer, specifically address certain types of leukemia or solid tumors. Onivyde, Vyxeos, and Marqibo play a critical role in oncology by offering treatment options for specific cancer types resistant to conventional chemotherapy or requiring liposomal drug delivery.

In December 2021, AstraZeneca, a UK-headquartered research-based biopharmaceutical firm, entered into a collaboration with professors Fredrik Hook and Elin Esbjorner of Chalmers University of Technology in Sweden, the terms of which were not disclosed. The collaboration is specifically oriented towards advancing the field of lipid nanoparticles (LNPs) for intracellular transport of nucleotide-based therapeutics, as well as the efficient production of protein therapeutics within cells. The partnership leverages the expertise of Fredrik Hook and Elin Esbjorner, who hold positions as professors at Chalmers University of Technology, a distinguished private research university based in Sweden.

Major companies operating in the liposomal drug delivery devices market report are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Medtronic PLC, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan NV, Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Ipsen SA, Novavax Inc., Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Tolmar Pharmaceuticals Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, Taiwan Liposome Company, T&T Scientific Corporation

North America was the largest region in the liposomal drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the global liposomal drug delivery devices market share. The regions covered in the liposomal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the liposomal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The liposomal drug delivery devices market consists of sales of instruments such as liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liposomal Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liposomal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liposomal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liposomal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Liposomal Doxorubicin; Liposomal Paclitaxel; Liposomal Amphotericin B; Other Types
• 2) By Application: Fungal Diseases; Cancer Therapy; Pain Management; Viral Vaccines; Photodynamic Therapy
• 3) By End User: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Novartis AG; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liposomal Drug Delivery Devices Market Characteristics

3. Liposomal Drug Delivery Devices Market Trends And Strategies

4. Liposomal Drug Delivery Devices Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Liposomal Drug Delivery Devices Market Size and Growth

• 5.1. Global Liposomal Drug Delivery Devices Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Liposomal Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Liposomal Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Liposomal Drug Delivery Devices Market Segmentation

• 6.1. Global Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Liposomal Doxorubicin
• Liposomal Paclitaxel
• Liposomal Amphotericin B
• Other Types
• 6.2. Global Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Fungal Diseases
• Cancer Therapy
• Pain Management
• Viral Vaccines
• Photodynamic Therapy
• 6.3. Global Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Other End Users

7. Liposomal Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Liposomal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Liposomal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Liposomal Drug Delivery Devices Market

• 8.1. Asia-Pacific Liposomal Drug Delivery Devices Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Liposomal Drug Delivery Devices Market

• 9.1. China Liposomal Drug Delivery Devices Market Overview
• 9.2. China Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Liposomal Drug Delivery Devices Market

• 10.1. India Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Liposomal Drug Delivery Devices Market

• 11.1. Japan Liposomal Drug Delivery Devices Market Overview
• 11.2. Japan Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Liposomal Drug Delivery Devices Market

• 12.1. Australia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Liposomal Drug Delivery Devices Market

• 13.1. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Liposomal Drug Delivery Devices Market

• 14.1. South Korea Liposomal Drug Delivery Devices Market Overview
• 14.2. South Korea Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Liposomal Drug Delivery Devices Market

• 15.1. Western Europe Liposomal Drug Delivery Devices Market Overview
• 15.2. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Liposomal Drug Delivery Devices Market

• 16.1. UK Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Liposomal Drug Delivery Devices Market

• 17.1. Germany Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Liposomal Drug Delivery Devices Market

• 18.1. France Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Liposomal Drug Delivery Devices Market

• 19.1. Italy Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Liposomal Drug Delivery Devices Market

• 20.1. Spain Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Liposomal Drug Delivery Devices Market

• 21.1. Eastern Europe Liposomal Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Liposomal Drug Delivery Devices Market

• 22.1. Russia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Liposomal Drug Delivery Devices Market

• 23.1. North America Liposomal Drug Delivery Devices Market Overview
• 23.2. North America Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Liposomal Drug Delivery Devices Market

• 24.1. USA Liposomal Drug Delivery Devices Market Overview
• 24.2. USA Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Liposomal Drug Delivery Devices Market

• 25.1. Canada Liposomal Drug Delivery Devices Market Overview
• 25.2. Canada Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Liposomal Drug Delivery Devices Market

• 26.1. South America Liposomal Drug Delivery Devices Market Overview
• 26.2. South America Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Liposomal Drug Delivery Devices Market

• 27.1. Brazil Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Liposomal Drug Delivery Devices Market

• 28.1. Middle East Liposomal Drug Delivery Devices Market Overview
• 28.2. Middle East Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Liposomal Drug Delivery Devices Market

• 29.1. Africa Liposomal Drug Delivery Devices Market Overview
• 29.2. Africa Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Liposomal Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Liposomal Drug Delivery Devices Market Competitive Landscape
• 30.2. Liposomal Drug Delivery Devices Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Services Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Medtronic plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Liposomal Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. Gilead Sciences Inc.
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Mylan NV
• 31.4. Sun Pharmaceutical Industries Ltd.
• 31.5. CSPC Pharmaceutical Group Limited
• 31.6. Ipsen SA
• 31.7. Novavax Inc.
• 31.8. Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd.
• 31.9. Nanomerics Ltd.
• 31.10. Luye Pharma Group Ltd.
• 31.11. Leadiant Biosciences Inc.
• 31.12. Pacira Biosciences Inc.
• 31.13. Tolmar Pharmaceuticals Inc.
• 31.14. Nippon Kayaku Co. Ltd.
• 31.15. Celsion Corporation

32. Global Liposomal Drug Delivery Devices Market Competitive Benchmarking

33. Global Liposomal Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Liposomal Drug Delivery Devices Market

35. Liposomal Drug Delivery Devices Market Future Outlook and Potential Analysis

• 35.1 Liposomal Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Liposomal Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Liposomal Drug Delivery Devices Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer